No abstract available
MeSH terms
-
Animals
-
Bone Density Conservation Agents / pharmacology*
-
Cell Nucleus / drug effects
-
Diphosphonates / pharmacology*
-
Disease Models, Animal
-
Drug Therapy, Combination
-
Farnesyltranstransferase / antagonists & inhibitors
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
-
Imidazoles / pharmacology*
-
Lamin Type A
-
Longevity / drug effects
-
Mice
-
Mice, Knockout
-
Nuclear Proteins / metabolism
-
Pravastatin / pharmacology*
-
Prenylation / drug effects
-
Progeria / drug therapy*
-
Progeria / genetics
-
Protein Precursors / metabolism
-
Tumor Suppressor Protein p53 / metabolism
-
Zoledronic Acid
Substances
-
Bone Density Conservation Agents
-
Diphosphonates
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Imidazoles
-
Lamin Type A
-
Nuclear Proteins
-
Protein Precursors
-
Tumor Suppressor Protein p53
-
prelamin A
-
Zoledronic Acid
-
Farnesyltranstransferase
-
Pravastatin